Circadian rhythm changes in people with CAPS
Official title: Identification of Circadian Rhythm Deregulation in Patients With Cryopyrin-associated Periodic Syndrome (CAPS)
Run by Hospices Civils de Lyon · NCT06544018 · Data updated 2026-11-12
This project will test whether people with CAPS have altered circadian rhythms by measuring sleep timing, saliva melatonin, and NLRP3 genetics and comparing them to healthy household members.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 6 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 6 sites (Bron and 5 other locations) |
| Status | Recruiting |
| Started | February 25, 2026 |
| Main results expected | February 25, 2029 |
| Study ends | February 25, 2029 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT06544018 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged 6 or older with genetically confirmed CAPS (NLRP3), weight ≥25 kg and consent, together with healthy household members of similar age and weight willing to undergo saliva sampling and genetic testing.
✕Probably not a fit
Patients with chronic sleep disorders requiring medication or those without an NLRP3 mutation are unlikely to gain direct benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional protocol compares circadian biology in patients with CAPS (confirmed by NLRP3 genetic analysis) to healthy household controls. Participants aged 6 and older provide saliva samples for melatonin measurement, complete sleep and symptom questionnaires including the AIDAI score, and undergo circadian rhythm monitoring. Genetic analysis of NLRP3 will confirm diagnosis and permit exploration of links between genotype and circadian markers. Subjects with chronic medicated sleep disorders are excluded to reduce confounding.
Why it matters
Potential benefit: If successful, the work could reveal circadian disruption as a treatable feature of CAPS and suggest timing-based or anti-inflammasome strategies to reduce symptoms.
How similar studies have gone: Preclinical and clinical research links circadian regulation to NLRP3 inflammasome activity, but circadian profiling specifically in genetically confirmed CAPS patients is novel and not yet established.
Who can join: the full rules
Show full inclusion / exclusion criteria
---Inclusion Criteria: Patient with CAPS group : * Patients aged 6 and over * Participant with CAPS confirmed by NLRP3 genetic analysis * Weight greater than or equal to 25 Kg * Parents/guardians who have been informed of the study and have signed a consent form. * Patient affiliated to a social security scheme Control group (healthy participant): * Participant aged 6 and over * Weight greater than or equal to 25 Kg * Participant living in the same household as a subject with CAPS genetically confirmed by NLRP3 analysis and included in the protocol * Participant with no CAPS (a priori) who consents to NLRP3 genetic analysis * Parents/guardians who have been informed of the study and have signed a consent form. * Participant who has been informed of the study and has agreed to take part * Participant affiliated to a social security scheme * Exclusion Criteria : Patient with CAPS group : * Patients with chronic sleep disorders (narcolepsy, hypersomnia) requiring medication (sleeping pills, melatonin). * Patients with sleep apnea syndrome * Patients working regular night shifts or alternating day and night shifts * Pregnant or breast-feeding women * Parents with an infant under 6 months of age * Patient participating in another interventional drug study * Deprivation of civil rights (curators, guardianship, safeguard of justice) Control group (healthy participant): * Participants with a chronic illness (ALD beneficiaries) * Participants with chronic sleep disorders (narcolepsy, hypersomnia) requiring medication (sleeping pills, melatonin) * Participants working regular night shifts or alternating day and night shifts * Pregnant or breast-feeding women * Parents with an infant under 6 months of age * Participant participating in another interventional drug study * Deprivation of civil rights (curators, guardianship, safeguard of justice)
Where it's running
-
Hôpital Femme-Mère-Enfant (HCL)
Bron, France Recruiting -
Hôpital Claude Huriez (CHU de Lille)
Lille, France Not yet recruiting -
Hôpital de la Croix-Rousse (HCL)
Lyon, France Not yet recruiting -
Hôpital Edouard Herriot (HCL)
Lyon, France Not yet recruiting -
Hôpital Tenon (AP-HP)
Paris, France Not yet recruiting -
Hôpital Kremlin-Bicêtre (AP-HP)
Paris, France Not yet recruiting
Study contacts
- Study coordinator: Alexandre Alexandre, PR
- Email: Alexandre.belot@chu-lyon.fr
- Phone: 04 27 85 61 26
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
Virus interactions in hospitalized patients during winter seasons in Lyon
This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs
This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.
-
French version validation of the New Mobility Score for older adults after hip fracture
This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.